lissamine rhodamine b has been researched along with Cancer of Prostate in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (84.62) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bijnsdorp, IV; Geldof, AA; Hoekstra, OS; Oprea-Lager, DE; van de Ven, PM; van den Eertwegh, AJ; van Kanten, MP; van Moorselaar, RJ | 1 |
| Abdel-Aziz, HA; Alsherbiny, MA; Aly, MH; Eldehna, WM; Fares, M; Ghabbour, HA; Ibrahim, HS | 1 |
| Amadori, D; Brigliadori, G; Carloni, S; Fabbri, F; Silvestrini, R; Tesei, A; Ulivi, P; Vannini, I; Zoli, W | 1 |
| Echner, H; Heckl, S; Sturzu, A | 1 |
| Eid, MA; El Etreby, F; Kumar, MV; Lewis, RW; Liang, Y | 1 |
| Incles, CM; Kelland, LR; Kempski, H; Koehler, H; Neidle, S; Schultes, CM | 1 |
| Guh, JH; Huang, DM; Huang, YT; Kung, FL; Shen, YC; Teng, CM; Wu, C | 1 |
| Chen, IL; Guh, JH; Huang, DM; Huang, YT; Teng, CM; Tzeng, CC | 1 |
| Fitzgerald, TJ; Goel, HL; Languino, LR; Simon, EL; Teider, N; Wang, T | 1 |
| Apan, TR; Chávez, IO; Martínez-Vázquez, M | 1 |
| Dalton, JT; Hwang, DJ; Miller, DD; Mohler, ML; Rakov, IM; Xu, H; Yang, J | 1 |
| Chodyński, M; Fitak, H; Kutner, A; Opolski, A; Wietrzyk, J; Wojdat, E | 1 |
| Kennedy, AR; Wan, XS | 1 |
13 other study(ies) available for lissamine rhodamine b and Cancer of Prostate
| Article | Year |
|---|---|
[18F]fluoromethylcholine as a chemotherapy response read-out in prostate cancer cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Choline; Docetaxel; Drug Screening Assays, Antitumor; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Inhibitory Concentration 50; Male; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Rhodamines; Taxoids | 2015 |
Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Doxorubicin; Drug Screening Assays, Antitumor; Female; Humans; Indoles; Male; MCF-7 Cells; Prostatic Neoplasms; Rhodamines; Structure-Activity Relationship; Urea | 2016 |
Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.
Topics: Annexin A5; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma; Caspase 3; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Diphosphonates; Docetaxel; Drug Synergism; Enzyme Activation; Fluorescent Dyes; Humans; Imidazoles; In Situ Nick-End Labeling; Male; MAP Kinase Kinase 1; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Taxoids; Time Factors; Zoledronic Acid | 2008 |
The lily-of-the-valley fragrance receptor--potential in prostate cancer imaging.
Topics: Aldehydes; Animals; Cell Line, Tumor; Fluorescent Dyes; HeLa Cells; Humans; Jurkat Cells; Male; Mice; Mice, Nude; Microscopy, Confocal; Prostatic Neoplasms; Receptors, Odorant; Rhodamines; Transplantation, Heterologous | 2009 |
Mifepristone-induced secretion of transforming growth factor beta1-induced apoptosis in prostate cancer cells.
Topics: Animals; Apoptosis; Caspase 3; Caspases; Cell Survival; Cytochrome c Group; Cytosol; Enzyme-Linked Immunosorbent Assay; Estrogen Antagonists; Fluorescent Dyes; Humans; Immunoblotting; Male; Mice; Mice, Nude; Mifepristone; Prostatic Neoplasms; Rhodamines; Tamoxifen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
A G-quadruplex telomere targeting agent produces p16-associated senescence and chromosomal fusions in human prostate cancer cells.
Topics: 3T3 Cells; Acridines; Animals; Blotting, Western; Catalysis; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Chromosomes; Cyclin-Dependent Kinase Inhibitor p16; DNA; G-Quadruplexes; Humans; Ligands; Male; Metaphase; Mice; Models, Chemical; Nucleic Acid Conformation; Prostatic Neoplasms; Rhodamines; Telomerase; Telomere; Time Factors; Up-Regulation | 2004 |
Investigation of extrinsic and intrinsic apoptosis pathways of new clerodane diterpenoids in human prostate cancer PC-3 cells.
Topics: Apoptosis; Blotting, Western; Caspase Inhibitors; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Diterpenes; Diterpenes, Clerodane; Enzyme Activation; Fas Ligand Protein; Genes, bcl-2; Humans; In Situ Nick-End Labeling; Male; Membrane Glycoproteins; Myeloid Cell Leukemia Sequence 1 Protein; Neoplasm Proteins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Signal Transduction; Tetrazolium Salts; Thiazoles | 2004 |
CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line.
Topics: Amino Acid Chloromethyl Ketones; Antineoplastic Agents; Apoptosis; Blotting, Western; Caspase 3; Caspases; CDC2 Protein Kinase; Cell Cycle; Cell Line, Tumor; Coloring Agents; Cyclin B; Cyclin B1; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flow Cytometry; Humans; Inhibitor of Apoptosis Proteins; Male; Microscopy, Fluorescence; Microtubule-Associated Proteins; Microtubules; Mitosis; Neoplasm Metastasis; Neoplasm Proteins; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Rhodamines; Survivin; Tetrazolium Salts; Thiazoles; Time Factors; Up-Regulation | 2005 |
High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression.
Topics: Apoptosis; Cell Adhesion; Cell Division; Cell Line, Tumor; Extracellular Matrix; Fibronectins; Fluorescent Dyes; Humans; Integrin beta1; Male; Prostatic Neoplasms; Radiation Dosage; Rhodamines | 2005 |
Cytotoxic activity and effect on nitric oxide production of tirucallane-type triterpenes.
Topics: Anacardiaceae; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Death; Cell Line, Tumor; Central Nervous System Neoplasms; Colonic Neoplasms; Drug Screening Assays, Antitumor; Female; Hexanes; Humans; Leukemia; Lipopolysaccharides; Macrophages, Peritoneal; Male; Medicine, Traditional; Mexico; Mice; Nitric Oxide; Plant Extracts; Prostatic Neoplasms; Rhodamines; Triterpenes; Ursolic Acid | 2005 |
Arylisothiocyanato selective androgen receptor modulators (SARMs) for prostate cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Chemical Phenomena; Chemistry, Physical; Haplorhini; Humans; Isothiocyanates; Ligands; Magnetic Resonance Spectroscopy; Male; Prostatic Neoplasms; Receptors, Androgen; Rhodamines; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2006 |
Antitumor properties of diastereomeric and geometric analogs of vitamin D3.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Calcitriol; Calcium; Carcinoma, Lewis Lung; CD11b Antigen; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Coloring Agents; Female; Fibroblasts; HL-60 Cells; Humans; Lipopolysaccharide Receptors; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Pancreatic Neoplasms; Prostatic Neoplasms; Rhodamines; Stereoisomerism; Tetrazolium Salts; Thiazoles | 2007 |
Effects of the Bowman-Birk inhibitor on growth, invasion, and clonogenic survival of human prostate epithelial cells and prostate cancer cells.
Topics: Basement Membrane; Cell Division; Cell Survival; Chemotactic Factors; Clone Cells; Fluorescent Dyes; Humans; Male; Neoplasm Invasiveness; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rhodamines; Trypsin Inhibitor, Bowman-Birk Soybean; Trypsin Inhibitors; Tumor Cells, Cultured | 2002 |